Pivot Pharmaceuticals (CSE:PVOT; OTCQB:PVOTF) announced its California-based subsidiary Pivot Naturals signed a definitive manufacturing and supply agreement with a brand of cannabis products in the state, Stoney.
As quoted in the press release:
Under the terms of the Agreement, Stoney has agreed to purchase Pivot’s suite of Ready-To-Infuse-Cannabis (“RTIC”) powderized products, including formulated capsules for targeted effects, bulk powder for baking additives, single serve stick packs and pet food supplements. These finished products will be marketed under the established and respected “Stoney” and “Halo” brands. Order quantities will be determined in rolling 30-day periods commencing in 2018.
Mr. Ivan Villa, President of Stoney LLC stated “We are excited to partner with Pivot and their patented superior technology to provide our customers additional choices throughout our high-quality Stoney and Halo brands. Our customers have been demanding this level of bioavailability technology with targeted effects and we are thrilled that we will be able to deliver on their expectations. The RTIC cannabis powder is revolutionary, simple to use, doseable, flavorless and odourless. We look forward to having a long and prosperous relationship with Pivot as our brands continue to increase market share in the large California cannabis derivatives market.”
Click here to read the full press release.
The post Pivot Signs Agreement with Cannabis Brand Stoney appeared first on Investing News Network.